ProgramsView all programs
From the news
- Chancellor Amma Addresses the Parliament of World’s Religions
- Amrita Students Qualify for the European Mars Rover Challenge
Publication Type : Journal Article
Thematic Areas : Medical Sciences
Publisher : Biomark Res
Source : Biomark Res, Volume 6, p.23 (2018)
Campus : Kochi
School : School of Medicine, Center for Nanosciences
Center : Nanosciences, Amrita Center for Nanosciences and Molecular Medicine Move
Department : Nanosciences and Molecular Medicine, Urology
Year : 2018
Abstract : strongBackground: /strongCarcinogenesis is a multistep process which involves interplay between the tumour cells and the matrix proteins. This occurs by adherence between the tumour cells and proteins in the extracellular matrix. VHL mutation affects through the hypoxia inducible factor (HIF) and causes changes in various tissue proteins like VEGF, PDGF, TGF, Fibronectin and others. As not much literature is available, we aim to quantify the changes of fibronectin protein in renal cell carcinoma (RCC) tissue.strongMethods: /strongThis Prospective unbalanced case control study was conducted over a period of 18nbsp;months from April 2016 to September 2017. The patients undergoing nephrectomy for the diagnosis of RCC were included in the study after obtaining written informed consent. Patients were excluded from study, if normal renal tissue could not be identified in the resected kidney and if the artery clamp time to retrieval of tissue was more than 30nbsp;min. Fibronectin protein is estimated in the tumour tissue by gel electrophoresis and western blotting which is compared with that of normal kidney tissue of the same kidney. Results have been expressed as absolute values with standard deviation and relative expression (RE).strongResults: /strongOf the 21 patients analysed 15 showed an increase in fibronectin expression in the renal tumour tissue while 6 did not. The mean expression of Fibronectin protein has increased 1.5 times in the tumour tissue when compared with the normal tissue. The increase was 1.54 times in early tumours compared to 1.37 times in advanced tumours of RCC.strongConclusions: /strongFibronectin showed a 1.5 times increase in the tumour compared to normal. This increase is more in Stage 1amp;2 tumours when compared to the Stage 3amp;4 tumours.
Cite this Research Publication : Sandeep Kondisetty, Krishnakumar N. Menon, and Ginil Kumar Pooleri, “Fibronectin protein expression in renal cell carcinoma in correlation with clinical stage of tumour.”, Biomark Res, vol. 6, p. 23, 2018.